Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IQE plc: Director/PDMR Shareholding

1st Dec 2025 13:30

RNS Number : 7235J
IQE PLC
01 December 2025
 

IQE plc

 

 

Cardiff, UK

1 December 2025

 

 

Issue of Options Director/PDMR Shareholding

 

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, advises that on 1 December 2025, Mark Cubitt, Executive Chair received a grant of nil cost share options ("Options") over ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to IQE's Long Term Incentive Plan ("LTIP").

Mark Cubitt has received immediately vested Options over 166,667 Ordinary Shares under the LTIP. Further to the grants made on 8 June 2025 and 1 September 2025, it is intended that Mark will be granted an Option over a further 166,666 Ordinary Shares at the start of the next subsequent calendar quarter in March 2026, provided that he has not returned to his non-executive chair role prior to that date. The total number of Options granted to Mark will therefore be 666,667. Mark's Options and resulting Ordinary Shares are subject to a three-year holding period from the date of grant.

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Mark Cubitt

Jutta Meier

Amy Barlow

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

· Smart Connected Devices

· Communications Infrastructure

· Automotive and Industrial

· Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

Mr Mark Cubitt

2.

Reason for the notification

a)

Position / status

PDMR (Executive Chair)

b)

Initial notification / amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQE plc

 

b)

Legal Entity Identifier

213800Y33WHD3ESJJP16

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 1 pence each in the CompanyGB0009619924

 

b)

Nature of the transaction

Award of options

 

c)

Price(s) and volume(s)

166,667 Ordinary Shares

d)

Aggregated information

·  Aggregated volume

·  Aggregated price

e)

Date of the transaction(s)

1 December 2025

 

f)

Place of the transaction

Off-market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKDBDNBDDKBK

Related Shares:

IQE
FTSE 100 Latest
Value9,692.07
Change-9.73